Moderna Inc (MRNA)
107.97
+1.79
(+1.69%)
USD |
NASDAQ |
Apr 26, 16:00
107.80
-0.16
(-0.15%)
After-Hours: 20:00
Moderna Profit Margin (Quarterly): 7.71% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.71% |
| September 30, 2023 | -203.1% |
| June 30, 2023 | -436.7% |
| March 31, 2023 | 4.30% |
| December 31, 2022 | 28.45% |
| September 30, 2022 | 32.39% |
| June 30, 2022 | 48.12% |
| March 31, 2022 | 61.57% |
| December 31, 2021 | 70.05% |
| September 30, 2021 | 69.02% |
| June 30, 2021 | 65.95% |
| March 31, 2021 | 70.05% |
| December 31, 2020 | -119.2% |
| Date | Value |
|---|---|
| September 30, 2020 | -1.94K% |
| June 30, 2020 | -403.4% |
| March 31, 2020 | -3.10K% |
| December 31, 2019 | -1.17K% |
| September 30, 2019 | -923.8% |
| June 30, 2019 | -1.35K% |
| March 31, 2019 | -939.3% |
| December 31, 2018 | -431.0% |
| September 30, 2018 | -219.1% |
| June 30, 2018 | -350.7% |
| March 31, 2018 | -263.6% |
| December 31, 2017 | -42.92% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-3.10K%
Minimum
Mar 2020
70.05%
Maximum
Dec 2021
-483.6%
Average
4.30%
Median
Mar 2023
Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 23.41% |
| Merck & Co Inc | 30.19% |
| Pfizer Inc | -23.64% |
| Johnson & Johnson | 25.04% |
| Novavax Inc | -70.40% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -28.66% |
| Return on Assets | -21.48% |
| Return on Invested Capital | -28.66% |
| Gross Profit Margin (Quarterly) | 66.97% |
| Operating Margin (Quarterly) | 0.21% |
| Return on Net Operating Assets | -90.93% |